Humes H D, Weinberg J M, Knauss T C
Am J Kidney Dis. 1982 Jul;2(1):5-29. doi: 10.1016/s0272-6386(82)80039-5.
Aminoglycoside antibiotics continue to be a mainstay of therapy in the clinical management of gram negative infections, but a major factor in the clinical use of aminoglycosides is their nephrotoxicity. With gram negative organisms accounting for the majority of hospital acquired infections, the occurrence of aminoglycoside induced acute renal failure has become commonplace. Presently at least 10% of all cases of acute renal failure can be attributed to these antibiotics. This article will cover the renal handling of the aminoglycosides, the pathogenetic mechanisms of nephrotoxicity, and the clinical aspects of aminoglycoside induced acute renal failure with particular emphasis on recent data which have increased our understanding of the interaction of aminoglycosides with the renal tubular cell and the effects of this interaction on cellular function and integrity.
氨基糖苷类抗生素仍然是革兰氏阴性菌感染临床治疗的主要药物,但氨基糖苷类药物临床应用的一个主要因素是其肾毒性。由于革兰氏阴性菌是医院获得性感染的主要病原体,氨基糖苷类药物引起的急性肾衰竭已屡见不鲜。目前,所有急性肾衰竭病例中至少有10%可归因于这些抗生素。本文将涵盖氨基糖苷类药物的肾脏处理、肾毒性的发病机制以及氨基糖苷类药物引起的急性肾衰竭的临床情况,特别强调最近的数据,这些数据加深了我们对氨基糖苷类药物与肾小管细胞相互作用以及这种相互作用对细胞功能和完整性影响的理解。